| Financial Year |
March 31 2023 |
| Monetary Funds |
3,014,900,848.68 |
| Held-for-trading Financial Assets |
40,955,946.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
684,043,865.20 |
| Advances to Suppliers |
302,160,092.57 |
| Other Receivables |
155,652,671.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,403,985,479.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
786,233,257.80 |
| Total Current Assets |
9,114,420,882.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
142,465,395.28 |
| Fixed Assetes |
9,808,005,658.75 |
| Under-construction Projects |
3,360,917,495.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
309,194,052.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,268,202.26 |
| Deferred Income Tax Assets |
403,692,899.13 |
| Other Non-Current Assets |
272,113,154.99 |
| Sub-Total of Non-Current Assets |
14,304,656,858.41 |
| Total Assets |
23,419,077,740.69 |
| Short-Term Loans |
4,991,227,296.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,545,255,666.97 |
| Accounts Payable |
4,345,043,337.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
126,361,500.34 |
| Taxes Payable |
76,657,092.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,467,119.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,259,209,046.36 |
| Other Current Liabilities |
76,589,215.67 |
| Sub-Total of Current Liabilities |
14,065,893,155.59 |
| Long-term Loans |
2,383,290,054.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
810,200,193.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
106,008,809.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,327,737,957.26 |
| Total Liabilities |
17,393,631,112.85 |
| Paid-In Capital(Or Share Stock) |
1,336,844,288.00 |
| Capital Surplus |
1,333,081,291.92 |
| Surplus Reserve |
272,328,684.69 |
| LESS:Treasury Stock |
1,000,300,688.62 |
| Undistributed Profits |
4,075,064,050.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,025,446,627.84 |
| Owner's Equity（Stockholder's Equity） |
6,025,446,627.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,419,077,740.69 |
